PNC Financial Services Group Inc. Cuts Stock Position in Encompass Health Co. (NYSE:EHC)

PNC Financial Services Group Inc. cut its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 15.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 37,403 shares of the company's stock after selling 6,614 shares during the period. PNC Financial Services Group Inc.'s holdings in Encompass Health were worth $3,454,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. State Street Corp grew its holdings in shares of Encompass Health by 0.7% in the third quarter. State Street Corp now owns 3,025,769 shares of the company's stock valued at $292,410,000 after purchasing an additional 21,329 shares in the last quarter. Geode Capital Management LLC lifted its position in Encompass Health by 1.2% during the third quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company's stock valued at $161,781,000 after purchasing an additional 20,547 shares during the last quarter. Copeland Capital Management LLC increased its holdings in shares of Encompass Health by 0.7% in the 4th quarter. Copeland Capital Management LLC now owns 1,293,098 shares of the company's stock worth $119,418,000 after buying an additional 8,548 shares during the last quarter. Point72 Asset Management L.P. increased its holdings in shares of Encompass Health by 2,458.5% in the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company's stock worth $83,990,000 after buying an additional 835,135 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new position in shares of Encompass Health in the 4th quarter valued at about $77,944,000. Institutional investors own 97.25% of the company's stock.

Remove Ads

Encompass Health Trading Up 1.8 %

EHC stock traded up $1.75 during mid-day trading on Monday, reaching $97.73. The company had a trading volume of 575,468 shares, compared to its average volume of 633,969. The firm has a 50 day moving average of $97.35 and a 200 day moving average of $96.97. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. Encompass Health Co. has a 12 month low of $74.45 and a 12 month high of $104.55. The company has a market capitalization of $9.84 billion, a PE ratio of 21.91, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. On average, equities analysts predict that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.70%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's dividend payout ratio (DPR) is presently 15.25%.

Wall Street Analyst Weigh In

Several brokerages have weighed in on EHC. Barclays boosted their price objective on Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a research note on Friday, February 7th. Royal Bank of Canada restated an "outperform" rating and issued a $110.00 price target on shares of Encompass Health in a research report on Tuesday, February 11th. William Blair reiterated an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. StockNews.com raised shares of Encompass Health from a "hold" rating to a "buy" rating in a research note on Saturday, February 15th. Finally, KeyCorp lifted their price target on shares of Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a research note on Monday, February 10th. Ten analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus price target of $107.67.

Insiders Place Their Bets

In related news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 2.10% of the stock is owned by company insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.